论著

西藏地区肾穿刺活检术后出血风险分析

  • 张蕾 ,
  • 李国梁 ,
  • 党宗辉 ,
  • 次仁罗布 ,
  • 阿勇 ,
  • 吴玲洁 ,
  • 刘立军
展开
  • 1.西藏自治区人民医院肾脏内科, 拉萨 850000
    2.北京大学第一医院肾内科,北京大学肾脏病研究所, 北京 100034

收稿日期: 2019-07-16

  网络出版日期: 2021-04-21

Analysis of bleeding risk in percutaneous renal biopsy in Tibet

  • Lei ZHANG ,
  • Guo-liang LI ,
  • Zong-hui DANG ,
  • yong A ,
  • Ling-jie WU ,
  • Li-jun LIU
Expand
  • 1. Department of Nephrology, People’s Hospital of Tibet Autonomous Region, Lhasa 850000, China
    2. Renal Division, Institute of Nephrology, Peking University First Hospital, Beijing 100034, China

Received date: 2019-07-16

  Online published: 2021-04-21

摘要

目的: 观察我国西藏地区肾穿刺活检术(percutaneous renal biopsy,PRB)术后出血情况,分析总结与高原地区患者出血相关的危险因素,提高手术安全性。方法: 选择西藏自治区人民医院肾脏内科2016年5月至2018年5月收治的经皮肾穿刺活检术患者临床资料进行回顾性研究,分析诸因素(性别、年龄、血压、血红蛋白、血小板、血肌酐、凝血酶原时间和活化部分凝血酶原时间)与术后出血事件的相关性。结果: 共收集病例150例,平均年龄(41.2±15.6)岁,其中男性比例为58.7%(88/150),女性为41.3%(62/150),术后出血12例(男、女各6例),出血比例8.0%(12/150)。出血组平均年龄与无出血组相比,有偏高趋势[(48.3±20.0)岁vs. (40.6±15.1)岁,P=0.099]。出血组较无出血组高血压发生率、血红蛋白增多症发生率、尿素氮、凝血酶原时间差异均无统计学意义(P>0.05)。出血组血肌酐水平有高于无出血组趋势(P=0.090),出血组较无出血组活化部分凝血酶原时间有延长趋势(P=0.069)。出血组血小板计数明显低于无出血组(P<0.05)。多因素Logistic回归分析发现,活化部分凝血酶原时间延长和较低的血小板计数具有相对较高的出血风险,差异有统计学意义(P=0.079,P=0.082)。结论: 高原地区行PRB总体上是安全、可靠的;高龄、低血小板、肾功能下降、活化部分凝血酶原时间延长与PRB术后出血相关,高血红蛋白不是高原地区PRB术后出血的危险因素。

本文引用格式

张蕾 , 李国梁 , 党宗辉 , 次仁罗布 , 阿勇 , 吴玲洁 , 刘立军 . 西藏地区肾穿刺活检术后出血风险分析[J]. 北京大学学报(医学版), 2021 , 53(2) : 298 -301 . DOI: 10.19723/j.issn.1671-167X.2021.02.011

Abstract

Objective: To observe the postoperative bleeding after percutaneous renal biopsy (PRB) in Tibet, To analyze and summarize the risk factors associated with bleeding in high altitude patients to improve the safety of surgery. Methods: A retrospective analysis of 150 cases of PRB in the Department of Nephrology, People’s Hospital of Tibet Autonomous Region from May 2016 to May 2018 were carried out, and the correlations between the potential risk factors (gender, age, blood pressure, hemoglobin, platelet, serum creatinine) and postoperative bleeding events were analyzed. Results: During the study period, the 150 patients receiving procedure of PRB were enrolled in our hospital, with an average age of (41.2±15.6) years, of whom 58.7% (88/150) were male, 41.3% (62/150) were female, and major bleeding complications occurred in 12 biopsies (8.0%, 12/150). Six cases for men and women, respectively. The mean age in the bleeding group seemed to be higher than that in the non-bleeding group [(48.3±20.0) years vs. (40.6±15.1) years, P=0.099]. There was no significant difference in the incidence of hypertension, hemoglobinemia, urea nitrogen and prothrombin time between the two groups. The level of serum creatinine in the hemorrhage group seemed to be higher than that in the non-bleeding group (P=0.090), and the time of the hemorrhagic group was longer than that in the non-bleeding group (P=0.069). The platelet count in the bleeding group was significantly lower than that in the non-bleeding group (P<0.05). Multivariate Logistic regression analysis showed that the prolonged activation of partial prothrombin time and lower platelet count had a relatively high risk of bleeding, which was statistically significant (P=0.079, P=0.082). Conclusion: PRB is safe and reliable on the whole in plateau areas; Old age, low platelet count, decreased renal function and prolonged activated partial coagulation time are related to postoperative bleeding of PRB, and hyperhemoglobin is not a risk factor for bleeding. High hemoglobin is not a risk factor for postoperative bleeding of PRB at high altitude.

参考文献

[1] Torres-Munoz A, Valdez-Ortiz R, Gonzalez-Parra C, et al. Percutaneous renal biopsy of native kidneys: efficiency, safety and risk factors associated with major complications[J]. Arch Med Sci, 2011,7(5):823-831.
[2] Xu DM, Chen M, Zhou FD, et al. Risk Factors for severe bleeding complications in percutaneous renal biopsy[J]. Am J Med Sci, 2017,353(3):230-235.
[3] Korbet SM, Volpini KC, Whittier WL. Percutaneous renal biopsy of native kidneys: a single-center experience of 1,055 biopsies[J]. Am J Nephrol, 2014,39(2):153-162.
[4] Prasad N, Kumar S, Manjunath R, et al. Real-time ultrasound-guided percutaneous renal biopsy with needle guide by nephrologists decreases post-biopsy complications[J]. Clin Kidney J, 2015,8(2):151-156.
[5] Manno C, Strippoli GF, Arnesano L, et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy[J]. Kidney Int, 2004,66(4):1570-1577.
[6] 高文祥, 高玉琪. 慢性高原病分型、诊断与治疗的研究进展[J]. 第三军医大学学报 2016,38(5):431-436.
[7] Surgeons ACo: advanced trauma life support[M]. 10th ed. American: American College of Surgeons, 2018: 474.
[8] Corapi KM, Chen JL, Balk EM, et al. Bleeding complications of native kidney biopsy: a systematic review and meta-analysis[J]. Am J Kidney Dis, 2012,60(1):62-73.
[9] Al Turk AA, Estiverne C, Agrawal PR, et al. Trends and outcomes of the use of percutaneous native kidney biopsy in the United States: 5-year data analysis of the nationwide inpatient sample[J]. Clin Kidney J, 2018,11(3):330-336.
[10] Tondel C, Vikse BE, Bostad L, et al. Safety and complications of percutaneous kidney biopsies in 715 children and 8 573 adults in Norway 1988-2010[J]. Clin J Am Soc Nephrol, 2012,7(10):1591-1597.
[11] Lees JS, McQuarrie EP, Mordi N, et al. Risk factors for bleeding complications after nephrologist-performed native renal biopsy[J]. Clin Kidney J, 2017,10(4):573-577.
[12] Eiro M, Katoh T, Watanabe T. Risk factors for bleeding complications in percutaneous renal biopsy[J]. Clin Exp Nephrol, 2005,9(1):40-45.
[13] Martin DS, Pate JS, Vercueil A, et al. Reduced coagulation at high altitude identified by thromboelastography[J]. Thromb Haemost, 2012,107(6):1066-1071.
[14] Chen W, Liu Q, Wang H, et al. Prevalence and risk factors of chronic kidney disease: a population study in the Tibetan population[J]. Randomized Controlled Trial, 2011,26(5):1592-1599.
[15] Jonathan JH, Michaela M, Jeffrey SB. The native kidney biopsy: update and evidence for best practice[J]. Clin J Am Soc Nephrol, 2016,11(2):354-362.
[16] Preuss S, Kuechle C, Wagenpfeil S, et al. Retrospective analysis of ultrasound-detected bleeding complications after ultrasound-guided transcutaneous kidney biopsies[J]. Ultrasound Med Biol, 2017,43(1):153-162.
[17] Riehl J, Maigatter S, Kierdorf H, et al. Percutaneous renal biopsy: comparison of manual and automated puncture techniques with native and transplanted kidneys[J]. Nephrol Dial Transplant, 1994,9(11):1568-1574.
[18] Pokhrel A, Agrawal RK, Baral A, et al. Percutaneous renal biopsy: comparison of blind and real-time ultrasound guided technique[J]. J Nepal Health Res Counc, 2018,16(1):66-72.
[19] Mai J, Yong J, Dixson H, et al. Is bigger better? A retrospective analysis of native renal biopsies with 16 Gauge versus 18 Gauge automatic needles[J]. Nephrology (Carlton), 2013,18(7):525-530.
文章导航

/